IKPM logo

Ikapharmindo Putramas IDX:IKPM Stock Report

Last Price

Rp238.00

Market Cap

Rp400.9b

7D

-1.7%

1Y

-4.8%

Updated

06 May, 2025

Data

Company Financials

PT Ikapharmindo Putramas Tbk

IDX:IKPM Stock Report

Market Cap: Rp400.9b

IKPM Stock Overview

Engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. More details

IKPM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health2/6
Dividends1/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

PT Ikapharmindo Putramas Tbk Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ikapharmindo Putramas
Historical stock prices
Current Share PriceRp238.00
52 Week HighRp308.00
52 Week LowRp195.00
Beta0
1 Month Change5.31%
3 Month Change-3.25%
1 Year Change-4.80%
3 Year Changen/a
5 Year Changen/a
Change since IPO31.49%

Recent News & Updates

Recent updates

Shareholder Returns

IKPMID Personal ProductsID Market
7D-1.7%-5.6%2.8%
1Y-4.8%-21.7%-2.4%

Return vs Industry: IKPM exceeded the ID Personal Products industry which returned -21.4% over the past year.

Return vs Market: IKPM underperformed the ID Market which returned -3.3% over the past year.

Price Volatility

Is IKPM's price volatile compared to industry and market?
IKPM volatility
IKPM Average Weekly Movement4.3%
Personal Products Industry Average Movement5.9%
Market Average Movement7.2%
10% most volatile stocks in ID Market14.5%
10% least volatile stocks in ID Market3.5%

Stable Share Price: IKPM has not had significant price volatility in the past 3 months compared to the ID market.

Volatility Over Time: IKPM's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19781,046. Kartonowww.ikapharmindo.com

PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and nutraceuticals; and over-the-counter drugs.

PT Ikapharmindo Putramas Tbk Fundamentals Summary

How do Ikapharmindo Putramas's earnings and revenue compare to its market cap?
IKPM fundamental statistics
Market capRp400.95b
Earnings (TTM)Rp5.01b
Revenue (TTM)Rp412.07b

80.0x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IKPM income statement (TTM)
RevenueRp412.07b
Cost of RevenueRp226.54b
Gross ProfitRp185.53b
Other ExpensesRp180.51b
EarningsRp5.01b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.98
Gross Margin45.02%
Net Profit Margin1.22%
Debt/Equity Ratio69.5%

How did IKPM perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

22%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/06 14:11
End of Day Share Price 2025/05/06 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT Ikapharmindo Putramas Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.